Jay Pepose's most recent trade in Opus Genetics Inc. was a trade of 41,143 Common Stock done . Disclosure was reported to the exchange on June 11, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Opus Genetics Inc. | Jay Pepose | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 41,143 | 180,458 | - | 0 | Common Stock | |
Opus Genetics Inc. | Jay Pepose | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 35,181 | 35,181 | - | - | Stock Option (Right to Buy) | |
Opus Genetics Inc. | Jay Pepose | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Apr 2024 | 48,000 | 48,000 | - | - | Stock Option (right to buy) | |
Opus Genetics Inc. | Jay Pepose | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Apr 2024 | 32,000 | 139,315 | - | 0 | Common Stock | |
Opus Genetics Inc. | Jay Pepose | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2024 | 14,964 | 107,315 | - | - | Common Stock | |
Opus Genetics Inc. | Jay Pepose | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 10,976 | 57,351 | - | 0 | Common Stock | |
Opus Genetics Inc. | Jay Pepose | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 9,639 | 9,639 | - | - | Stock Option | |
Opus Genetics Inc. | Jay Pepose | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2023 | 33,291 | 33,291 | - | - | Stock Option (right to buy) | |
Opus Genetics Inc. | Jay Pepose | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2023 | 13,013 | 45,907 | - | - | Common Stock | |
Opus Genetics Inc. | Jay Pepose | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 9,900 | 32,894 | - | - | Common Stock | |
Opus Genetics Inc. | Jay Pepose | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2022 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
Opus Genetics Inc. | Jay Pepose | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Apr 2022 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
Opus Genetics Inc. | Jay Pepose | Director | Purchase of securities on an exchange or from another person at price $ 3.65 per share. | 13 Dec 2021 | 8,250 | 22,994 | - | 3.7 | 30,113 | Common Stock |
Opus Genetics Inc. | Jay Pepose | Director | Purchase of securities on an exchange or from another person at price $ 4.75 per share. | 13 Sep 2021 | 12,631 | 14,744 | - | 4.7 | 59,997 | Common Stock |
Opus Genetics Inc. | Jay Pepose | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2021 | 40,000 | 40,000 | - | - | Stock Option (right to buy) |